ArticleContemporary clinical trials communications2022

Exposure driven dose escalation design with overdose control: Concept and first real life experience in an oncology phase I trial.

Sandrine Micallef et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.